Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C24H22Cl2N6O3 |
| Molecular Weight | 513.376 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1NC(=O)NC2=CC=C(Cl)C=C2Cl)C(=O)C3=CN(C(C)C)C4=C3C(N)=NC=N4
InChI
InChIKey=VFCRSIORGUNNGT-UHFFFAOYSA-N
InChI=1S/C24H22Cl2N6O3/c1-12(2)32-10-15(20-22(27)28-11-29-23(20)32)21(33)13-4-7-19(35-3)18(8-13)31-24(34)30-17-6-5-14(25)9-16(17)26/h4-12H,1-3H3,(H2,27,28,29)(H2,30,31,34)
| Molecular Formula | C24H22Cl2N6O3 |
| Molecular Weight | 513.376 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:49:17 GMT 2025
by
admin
on
Mon Mar 31 21:49:17 GMT 2025
|
| Record UNII |
GMH17J9LHL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
GMH17J9LHL
Created by
admin on Mon Mar 31 21:49:17 GMT 2025 , Edited by admin on Mon Mar 31 21:49:17 GMT 2025
|
PRIMARY | |||
|
CHEMBL3545120
Created by
admin on Mon Mar 31 21:49:17 GMT 2025 , Edited by admin on Mon Mar 31 21:49:17 GMT 2025
|
PRIMARY | |||
|
717899-97-3
Created by
admin on Mon Mar 31 21:49:17 GMT 2025 , Edited by admin on Mon Mar 31 21:49:17 GMT 2025
|
PRIMARY | |||
|
16048643
Created by
admin on Mon Mar 31 21:49:17 GMT 2025 , Edited by admin on Mon Mar 31 21:49:17 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
In summary, detailed SAR studies were executed on the (4-amino-7H-pyrrolo(2,3-d)pyrimidin-5-yl)(phenyl)methanone template, producing potent inhibitors of Tie2 with IC50s ranging from 5-100 nM, identifying CE-245,677 and PF-371,989 for further preclinical study. Design, synthesis, inhibitor activity, selectivity profile, ADME properties as well as complete inhibitor chemical structures of analogs leading to the identification to CE-245,677 will be presented.
|